|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AAMES FINANCIAL CORP/DE, 10-Q, EX-11, 2000-11-14 |
Next: DUSA PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 28,656,000
<SECURITIES> 0
<RECEIVABLES> 379,285,000
<ALLOWANCES> 2,000,000
<INVENTORY> 249,444,000
<CURRENT-ASSETS> 655,385,000
<PP&E> 32,582,000
<DEPRECIATION> 21,816,000
<TOTAL-ASSETS> 666,151,000
<CURRENT-LIABILITIES> 302,815,000
<BONDS> 275,470,000
0
106,000
<COMMON> 6,000
<OTHER-SE> 87,754,000
<TOTAL-LIABILITY-AND-EQUITY> 666,151,000
<SALES> 59,913,000
<TOTAL-REVENUES> 59,913,000
<CGS> 4,514,000
<TOTAL-COSTS> 4,514,000
<OTHER-EXPENSES> 39,661,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 15,009,000
<INCOME-PRETAX> 729,000
<INCOME-TAX> 36,000
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 693,000
<EPS-BASIC> (0.40)
<EPS-DILUTED> (0.40)
</TABLE>
|
|